Utility of a selective SHP2-inhibitor in KRAS-mutant cancerH. Hao, H. Wang,C. Liu, S. Kovats, R. Velazquez,H. Lu,B. Pant,J. Lim,M. Fleming,M. Shirley,M. Lamarche, S. Moody, S. Silver-Brown,G. Caponigro,T. Abrams,P. Hammerman,J. Williams, J. Engelman,S. Goldoni,M. MohseniEUROPEAN JOURNAL OF CANCER(2018)引用 0|浏览30暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要